Clinical Trial Update: LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating LifEStyle lifestyle intervention to enhance efficacy of neoadjuvant therapy in patients with early-stage triple-negative br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Triple Negative Breast Cancer (TNBC), Early Setting | Phase 2 | Status: RECRUITING